An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity

We evaluated enveloped virus-like particles (eVLPs) expressing various forms of the Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein and several adjuvants in an effort to identify a highly potent Coronavirus disease 2019 (COVID-19) vaccine candidate. eVLPs expressing a modi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fluckiger, Anne-Catherine, Ontsouka, Barthelemy, Bozic, Jasminka, Diress, Abebaw, Ahmed, Tanvir, Berthoud, Tamara, Tran, Anh, Duque, Diane, Liao, Mingmin, McCluskie, Michael, Diaz-Mitoma, Francisco, Anderson, David E., Soare, Catalina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282453/
https://www.ncbi.nlm.nih.gov/pubmed/34304928
http://dx.doi.org/10.1016/j.vaccine.2021.07.034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282453/
https://www.ncbi.nlm.nih.gov/pubmed/34304928
http://dx.doi.org/10.1016/j.vaccine.2021.07.034

Ejemplares similares